ethylmaleimide and u-50488

ethylmaleimide has been researched along with u-50488 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, C; Chen, Y; Huang, P; Li, JG; Liu-Chen, LY; Wang, Y	1
Arai, Y; Furuta, S; Kotlinska, J; Nakagawasai, O; Niijima, F; Sato, T; Satoh, S; Shimoda, M; Silberring, J; Sugawara, M; Tadano, T; Tan-No, K; Terenius, L; Watanabe, H	1

Other Studies

2 other study(ies) available for ethylmaleimide and u-50488

Article	Year
GEC1 interacts with the kappa opioid receptor and enhances expression of the receptor. The Journal of biological chemistry, 2006, Mar-24, Volume: 281, Issue:12 Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Adaptor Proteins, Signal Transducing; Amino Acid Sequence; Analgesics, Non-Narcotic; Animals; Blotting, Western; Brain; Cell Membrane; CHO Cells; Cricetinae; Cysteine; DNA, Complementary; Down-Regulation; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Estrogens; Ethylmaleimide; Flow Cytometry; Gene Expression Regulation; Glutathione Transferase; Glycoside Hydrolases; Glycosylation; Golgi Apparatus; Histidine; Humans; Immunoblotting; Immunohistochemistry; Immunoprecipitation; Kinetics; Methionine; Microscopy, Fluorescence; Microtubule-Associated Proteins; Molecular Sequence Data; Protein Binding; Protein Structure, Tertiary; Rats; Receptors, Opioid, kappa; Recombinant Fusion Proteins; RNA, Messenger; Sequence Homology, Amino Acid; Signal Transduction; Soluble N-Ethylmaleimide-Sensitive Factor Attachment Proteins; Time Factors; Transfection; Tubulin; Two-Hybrid System Techniques	2006
Cysteine protease inhibitors suppress the development of tolerance to morphine antinociception. Neuropeptides, 2008, Volume: 42, Issue:3 Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Opioid; Animals; Cysteine Proteinase Inhibitors; Drug Tolerance; Dynorphins; Ethylmaleimide; Formaldehyde; Injections, Spinal; Injections, Subcutaneous; Male; Mice; Morphine; Pain Measurement	2008

Article

Year

GEC1 interacts with the kappa opioid receptor and enhances expression of the receptor.

The Journal of biological chemistry, 2006, Mar-24, Volume: 281, Issue:12

Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Adaptor Proteins, Signal Transducing; Amino Acid Sequence; Analgesics, Non-Narcotic; Animals; Blotting, Western; Brain; Cell Membrane; CHO Cells; Cricetinae; Cysteine; DNA, Complementary; Down-Regulation; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Estrogens; Ethylmaleimide; Flow Cytometry; Gene Expression Regulation; Glutathione Transferase; Glycoside Hydrolases; Glycosylation; Golgi Apparatus; Histidine; Humans; Immunoblotting; Immunohistochemistry; Immunoprecipitation; Kinetics; Methionine; Microscopy, Fluorescence; Microtubule-Associated Proteins; Molecular Sequence Data; Protein Binding; Protein Structure, Tertiary; Rats; Receptors, Opioid, kappa; Recombinant Fusion Proteins; RNA, Messenger; Sequence Homology, Amino Acid; Signal Transduction; Soluble N-Ethylmaleimide-Sensitive Factor Attachment Proteins; Time Factors; Transfection; Tubulin; Two-Hybrid System Techniques

2006

Cysteine protease inhibitors suppress the development of tolerance to morphine antinociception.

Neuropeptides, 2008, Volume: 42, Issue:3

Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Opioid; Animals; Cysteine Proteinase Inhibitors; Drug Tolerance; Dynorphins; Ethylmaleimide; Formaldehyde; Injections, Spinal; Injections, Subcutaneous; Male; Mice; Morphine; Pain Measurement

2008